RenovoRx logo

RenovoRx

RNXT | NASDAQ
Chart Builder DCF Calculator
$0.94
-$0.10 (-9.62%)
At close: Nov 16, 2026, 3:59 PM ET
$0.97
+$0.03 (+3.61%)
After-hours: Nov 16, 2026, 7:58 PM ET
-9.62%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
47.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #336/1021 (Top 33%)

Key Statistics

Market Data

Market Cap $45.11M
1D Range
0.90 1.06
52W Range
0.73 2.52

Valuation (TTM)

PE -2.94
PB 4.86
EV/EBITDA -2.77

Valuation (NTM)

Forward PE N/A
Forward PEG 0.60
Price Target $9.00
Loading financial charts...

Profile

RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative dru...

Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Aug 26, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.07
Miss -16.67%
REV
$1.07M
Beat +0.14%
Next Earnings
Mar 29, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$9.00
Upside
+857.45%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.